The effect of nebivolol on internal mammary artery blood flow during coronary artery bypass graft surgery

Perfusion
S SarikayaC Köksal

Abstract

During coronary artery bypass grafting (CABG), one of the most important complications related to the internal mammary artery (IMA) is perioperative spasm. Nebivolol causes endothelium-dependent vascular relaxation by increasing nitric oxide (NO) release and prevents endothelial dysfunction in long-term use. In our study, we measured the effect of a third generation beta blocker, nebivolol, on the flow dynamics of IMA grafts. We recruited 90 hypertensive patients undergoing isolated CABG operation, who were divided into three groups and each group included 30 patients: Group 1 patients were under antihypertensive treatment other than beta-blockers (angiontensin-converting enzyme [ACE] inhibitors, calcium channel blockers or diuretics; monotherapy or combination therapy), Group 2 received metoprolol (50 mg/day) and Group 3 received nebivolol (5 mg/day). These antihypertensive therapies were given for at least one week before the operation and continued thereafter. IMA blood flow volume was measured for one minute just before cardiopulmonary bypass (measurement A) and before left internal mammary artery (LIMA)-left anterior descending (LAD) artery anastomosis (measurement B) in the three groups. Cardiac output measurements were a...Continue Reading

References

Jul 1, 1989·Circulation·P M Vanhoutte, H Shimokawa
Sep 1, 1982·The American Journal of Cardiology·A E BuxtonR N Edie
Oct 1, 1982·The Annals of Thoracic Surgery·H B BarnerD H Tyras
Feb 1, 1995·The Annals of Thoracic Surgery·L SassonA Schachner
Jan 1, 1993·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·E DregelidE Svendsen
May 22, 1998·The Annals of Thoracic Surgery·P J PearsonH V Schaff
Jan 1, 1996·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·W D MontgomeryW P Santamore
Aug 23, 2001·The Annals of Thoracic Surgery·J Chanda, C C Canver
Mar 1, 2007·Vascular Health and Risk Management·Robert Weiss
May 16, 2009·Therapeutic Advances in Cardiovascular Disease·Angelo Maffei, Giuseppe Lembo
Jun 17, 2009·Journal of Cardiovascular Pharmacology·R Preston MasonJames R Sowers
Aug 7, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Claudine M Baldwin, Susan J Keam
Oct 10, 2009·Journal of the American College of Cardiology·Thomas Münzel, Tommaso Gori
Jan 6, 2010·Korean Circulation Journal·Sang-Yong Yoo, Jang-Young Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.